Research

• Select this article
  • Xilin Yang,
  • Ying Wang,
  • Andrea O Y Luk,
  • Wing Yee So,
  • Ronald C W Ma,
  • Alice P S Kong,
  • Gang Xu,
  • and Juliana C N Chan

  Enhancers and attenuators of risk associations of chronic hepatitis B virus infection with hepatocellular carcinoma in type 2 diabetes

  Endocr Relat Cancer 20 (2) 161-171, doi:10.1530/ERC-12-0290 first published on 18 December 2012
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article
  • Amy A Lubik,
  • Jennifer H Gunter,
  • Brett G Hollier,
  • Susan Ettinger,
  • Ladan Fazli,
  • Nataly Stylianou,
  • Stephen C Hendy,
  • Hans H Adomat,
  • Martin E Gleave,
  • Michael Pollak,
  • Adrian Herington,
  • and Colleen C Nelson

  IGF2 increases de novo steroidogenesis in prostate cancer cells

  Endocr Relat Cancer 20 (2) 173-186, doi:10.1530/ERC-12-0250 first published on 14 January 2013
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article
  • Monica Ter-Minassian,
  • Jennifer A Chan,
  • Susanne M Hooshmand,
  • Lauren K Brais,
  • Anastassia Daskalova,
  • Rachel Heafield,
  • Laurie Buchanan,
  • Zhi Rong Qian,
  • Charles S Fuchs,
  • Xihong Lin,
  • David C Christiani,
  • and Matthew H Kulke

  Clinical presentation, recurrence, and survival in patients with neuroendocrine tumors: results from a prospective institutional database

  Endocr Relat Cancer 20 (2) 187-196, doi:10.1530/ERC-12-0340 first published on 14 January 2013
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article
  • Mercedes Tkach,
  • Cinthia Rosemblit,
  • Martín A Rivas,
  • Cecilia J Proietti,
  • María Celeste Díaz Flaqué,
  • María Florencia Mercogliano,
  • Wendy Beguelin,
  • Esteban Maronna,
  • Pablo Guzmán,
  • Felipe G Gercovich,
  • Ernesto Gil Deza,
  • Patricia V Elizalde,
  • and Roxana Schillaci

  p42/p44 MAPK-mediated Stat3Ser727 phosphorylation is required for progestin-induced full activation of Stat3 and breast cancer growth

  Endocr Relat Cancer 20 (2) 197-212, doi:10.1530/ERC-12-0194 first published on 17 January 2013
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
  • Supplementary Data
• Select this article
  • Ying-Cheng Chiang,
  • Ming-Cheng Chang,
  • Pao-Jen Chen,
  • Meei-Maan Wu,
  • Chang-Yao Hsieh,
  • Wen-Fang Cheng,
  • and Chi-An Chen

  Epigenetic silencing of BLU through interfering apoptosis results in chemoresistance and poor prognosis of ovarian serous carcinoma patients

  Endocr Relat Cancer 20 (2) 213-227, doi:10.1530/ERC-12-0117 first published on 17 January 2013
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article
  • Cecile N Chougnet,
  • Sophie Leboulleux,
  • Caroline Caramella,
  • Jean Lumbroso,
  • Isabelle Borget,
  • Désirée Déandreis,
  • Pierre Duvillard,
  • Dominique Elias,
  • Thierry de Baere,
  • Fritz-Line Vélayoudom-Céphise,
  • Joël Guigay,
  • Michel Ducreux,
  • Martin Schlumberger,
  • and Eric Baudin

  Frequency and characterization of gastro–entero–pancreatic neuroendocrine tumor patients with high-grade of uptake at somatostatin receptor scintigraphy

  Endocr Relat Cancer 20 (2) 229-239, doi:10.1530/ERC-12-0169 first published on 12 February 2013
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article
  • Zhaoxia Zhang,
  • Sasha Beyer,
  • and Sissy M Jhiang

  MEK inhibition leads to lysosome-mediated Na⁺/I⁻ symporter protein degradation in human breast cancer cells

  Endocr Relat Cancer 20 (2) 241-250, doi:10.1530/ERC-12-0342 first published on 12 February 2013
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article
  • Catherine M Olsen,
  • Christina M Nagle,
  • David C Whiteman,
  • Roberta Ness,
  • Celeste Leigh Pearce,
  • Malcolm C Pike,
  • Mary Anne Rossing,
  • Kathryn L Terry,
  • Anna H Wu,
  • The Australian Cancer Study (Ovarian Cancer),
  • Australian Ovarian Cancer Study Group,
  • Harvey A Risch,
  • Herbert Yu,
  • Jennifer A Doherty,
  • Jenny Chang-Claude,
  • Rebecca Hein,
  • Stefan Nickels,
  • Shan Wang-Gohrke,
  • Marc T Goodman,
  • Michael E Carney,
  • Rayna K Matsuno,
  • Galina Lurie,
  • Kirsten Moysich,
  • Susanne K Kjaer,
  • Allan Jensen,
  • Estrid Hogdall,
  • Ellen L Goode,
  • Brooke L Fridley,
  • Robert A Vierkant,
  • Melissa C Larson,
  • Joellen Schildkraut,
  • Cathrine Hoyo,
  • Patricia Moorman,
  • Rachel P Weber,
  • Daniel W Cramer,
  • Allison F Vitonis,
  • Elisa V Bandera,
  • Sara H Olson,
  • Lorna Rodriguez-Rodriguez,
  • Melony King,
  • Louise A Brinton,
  • Hannah Yang,
  • Montserrat Garcia-Closas,
  • Jolanta Lissowska,
  • Hoda Anton-Culver,
  • Argyrios Ziogas,
  • Simon A Gayther,
  • Susan J Ramus,
  • Usha Menon,
  • Aleksandra Gentry-Maharaj,
  • and Penelope M Webb
  • , the Ovarian Cancer Association Consortium

  Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium

  Endocr Relat Cancer 20 (2) 251-262, doi:10.1530/ERC-12-0395 first published on 12 February 2013
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Supplementary Data
• Select this article
  • Olga Husson,
  • Harm R Haak,
  • Liza N van Steenbergen,
  • Willy-Anne Nieuwlaat,
  • Boukje A C van Dijk,
  • Grard A P Nieuwenhuijzen,
  • Henrike Karim-Kos,
  • Johannes L Kuijpens,
  • Lonneke V van de Poll-Franse,
  • and Jan Willem W Coebergh

  Rising incidence, no change in survival and decreasing mortality from thyroid cancer in The Netherlands since 1989

  Endocr Relat Cancer 20 (2) 263-271, doi:10.1530/ERC-12-0336 first published on 27 February 2013
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only